MX351120B - Apósito médico. - Google Patents

Apósito médico.

Info

Publication number
MX351120B
MX351120B MX2016005642A MX2016005642A MX351120B MX 351120 B MX351120 B MX 351120B MX 2016005642 A MX2016005642 A MX 2016005642A MX 2016005642 A MX2016005642 A MX 2016005642A MX 351120 B MX351120 B MX 351120B
Authority
MX
Mexico
Prior art keywords
dressing
precursors
medical dressing
nitrogen monoxide
lighting module
Prior art date
Application number
MX2016005642A
Other languages
English (en)
Other versions
MX2016005642A (es
Inventor
V Suschek Christoph
Original Assignee
Bsn Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bsn Medical Gmbh filed Critical Bsn Medical Gmbh
Publication of MX2016005642A publication Critical patent/MX2016005642A/es
Publication of MX351120B publication Critical patent/MX351120B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/01—Non-adhesive bandages or dressings
    • A61F13/01021—Non-adhesive bandages or dressings characterised by the structure of the dressing
    • A61F13/01029—Non-adhesive bandages or dressings characterised by the structure of the dressing made of multiple layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)

Abstract

La presente invención se refiere a un apósito médico formado por al menos dos capas, que, por medio de la emisión de radiación electromagnética a partir de un módulo de luz, puede escindir precursores de monóxido de nitrógeno fotolábiles incorporados en un módulo de absorción adyacente al mismo, de modo que el monóxido de nitrógeno generado de manera fotolítica puede usarse como apoyo de terapias médicas en animales y seres humanos así como para generar NO.
MX2016005642A 2013-11-07 2014-11-07 Apósito médico. MX351120B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102013018642 2013-11-07
PCT/EP2014/074029 WO2015067746A1 (de) 2013-11-07 2014-11-07 Medizinische auflage

Publications (2)

Publication Number Publication Date
MX2016005642A MX2016005642A (es) 2016-10-28
MX351120B true MX351120B (es) 2017-10-03

Family

ID=51868962

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016005642A MX351120B (es) 2013-11-07 2014-11-07 Apósito médico.

Country Status (9)

Country Link
US (1) US10543293B2 (es)
EP (1) EP2981301B1 (es)
JP (1) JP6568519B2 (es)
CN (1) CN105979975B (es)
AU (1) AU2014345526B2 (es)
BR (1) BR112016009986B1 (es)
CA (1) CA2931174C (es)
MX (1) MX351120B (es)
WO (1) WO2015067746A1 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
CA2819475C (en) 2010-12-08 2019-02-12 Convatec Technologies Inc. Integrated system for assessing wound exudates
CA2819549C (en) 2010-12-08 2019-09-10 Convatec Technologies Inc. Wound exudate system accessory
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
GB201120693D0 (en) 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
CN105008611A (zh) 2012-12-20 2015-10-28 康沃特克科技公司 化学改性的纤维素纤维的处理
CN109564213B (zh) 2016-03-30 2023-01-31 西诺福有限公司 检测伤口微生物感染
MX2018011801A (es) 2016-03-30 2019-12-16 Convatec Technologies Inc Deteccion de infecciones microbianas en heridas.
PL3481360T3 (pl) 2016-07-08 2022-05-02 Convatec Technologies Inc. Wykrywanie przepływu płynu
EP3481348A4 (en) 2016-07-08 2020-02-26 ConvaTec Technologies Inc. FLUID COLLECTION APPARATUS
AU2017292881B2 (en) 2016-07-08 2022-03-17 Convatec Technologies Inc. Flexible negative pressure system
US10596388B2 (en) 2016-09-21 2020-03-24 Epistar Corporation Therapeutic light-emitting module
CA3040158A1 (en) 2016-10-18 2018-04-26 Marquette University Composite materials containing structural polymers and photoreactive nitric oxide releasing agents and uses thereof for wound dressings
MX2019009384A (es) * 2017-02-09 2019-12-11 Noxsano Inc Composiciones generadoras de gastrotransmisores electroquimicos y sus metodos de uso y apositos y sistemas de tratamiento que los incorporan.
US20200338228A1 (en) * 2017-11-13 2020-10-29 Kci Licensing, Inc. Light-responsive pressure sensitive adhesives for wound dressings
CN107823627A (zh) * 2017-12-01 2018-03-23 成都卓阳生物科技有限公司 一种还原型谷胱甘肽在制备治疗糖尿病足涂沫药剂中的应用
CN108771614B (zh) * 2018-03-05 2020-07-31 北京大学深圳医院 糖尿病理疗仪
EP3560544B1 (en) * 2018-04-26 2022-05-18 BSN medical GmbH Medical device for nitrogen monoxide (no)-assisted wound debridement
US10898606B2 (en) 2018-05-15 2021-01-26 Legacy Research and Development Group, LLC Self-fusing low density silicone
US11938236B2 (en) 2018-08-17 2024-03-26 Seoul Viosys Co., Ltd. Medical dressing
CN109045483B (zh) * 2018-09-17 2024-03-29 深圳市名家汇科技股份有限公司 一种理疗手套装置
KR20210064346A (ko) * 2018-09-27 2021-06-02 더 리젠츠 오브 더 유니버시티 오브 미시건 가스 전달 디바이스들
CN109758675A (zh) * 2019-01-29 2019-05-17 青岛中腾生物技术有限公司 一种自愈合医用凝胶
WO2021040814A1 (en) * 2019-08-23 2021-03-04 NOTA Laboratories, LLC Nitric oxide generating systems for nasal inhalation
CN112618158A (zh) * 2019-10-09 2021-04-09 咏达生医材料股份有限公司 一种供给一氧化氮的多层装置
WO2021068134A1 (zh) * 2019-10-09 2021-04-15 咏达生医材料股份有限公司 供给一氧化氮的多层装置
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
US20210228765A1 (en) * 2020-01-28 2021-07-29 Becton, Dickinson And Company Self-activating catheter insertion site dressing
CN111544774B (zh) * 2020-04-30 2022-07-15 北京夏禾科技有限公司 一种光疗袜
JP2021179605A (ja) * 2020-05-08 2021-11-18 日東電工株式会社 偏光フィルム積層体
WO2021263270A1 (en) * 2020-06-22 2021-12-30 Atacama, Llc Antimicrobial moisture avoidance powers and substances
CN113101053A (zh) * 2021-03-30 2021-07-13 上海健康医学院 一种可释放一氧化氮的创伤敷料
EP4353242A1 (en) * 2021-06-10 2024-04-17 Industry-University Cooperation Foundation Hanyang University ERICA Campus Pharmaceutical composition for burn treatment, comprising tmd nanosheet as an active ingredient
DE102021126687A1 (de) * 2021-10-14 2023-04-20 Global New Skin Cosmetics Gmbh Bioaktive Auflage zur topischen Anwendung, Verfahren zur deren Herstellung sowie Verwendung der bioaktiven Auflage
WO2023069641A1 (en) * 2021-10-22 2023-04-27 Sterile State, Llc Composition and composite article for forming nitric oxide
WO2023219811A1 (en) * 2022-05-12 2023-11-16 Sterile State, Llc Nitric oxide precursors and multi-component compositions for forming the same

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249109A (en) 1963-11-01 1966-05-03 Maeth Harry Topical dressing
DE2725261C2 (de) 1977-06-03 1986-10-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Transparentes Flüssigkeitsverbandmaterial, seine Herstellung und Verwendung
US4243656A (en) 1978-05-19 1981-01-06 Walliczek Erwin G Biosynthetic polymeric compositions
JPS6024807B2 (ja) 1979-02-19 1985-06-14 昭和電工株式会社 高吸水性ヒドロゲルの製造方法
CA1180622A (en) 1982-06-10 1985-01-08 Douglas G. Murray Coated wound dressing
DE3378185D1 (en) 1982-07-21 1988-11-17 Univ Strathclyde Composite wound dressing
JPH0780970B2 (ja) 1986-08-29 1995-08-30 三菱化学株式会社 吸水性複合材料の製造法
US4788237A (en) 1986-12-15 1988-11-29 Arco Chemical Company Sugar-containing water-absorbing composition which facilitates fiber formation
DE3903672C1 (es) 1989-02-08 1990-02-01 Lohmann Gmbh & Co Kg
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
DE4224325C1 (de) 1992-07-23 1994-02-10 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster für niedrigschmelzende und/oder flüchtige Wirkstoffe und Verfahren zu seiner Herstellung
US5405919A (en) 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
CA2169859A1 (en) 1993-09-13 1995-03-23 Niels Jacobsen Method and means for generating nitric oxide
US7105607B2 (en) 1994-04-19 2006-09-12 Applied Elastomerics, Inc. Tear resistant gels, composites, and articles
US5559165A (en) 1995-08-08 1996-09-24 National Starch And Chemical Investment Holding Corporation Hot melt adhesives for bonding to sensitive areas of the human body
DK174312B1 (da) 1996-06-06 2002-12-02 Ole Pedersen Fremgangsmåde til måling af strømningshastighed og diffusivitet, mikrosensor til brug ved fremgangsmåden samt anvendelse af sådan mikrosensor
US20030093143A1 (en) 1999-03-01 2003-05-15 Yiju Zhao Medical device having surface depressions containing nitric oxide releasing compound
US6639007B2 (en) 1996-11-15 2003-10-28 Tactyl Technologies, Inc. Elastomeric copolymer compositions and articles made therewith
US6620379B1 (en) * 1998-04-09 2003-09-16 S.P.M. Recovery Ltd. Apparatus and method of treatment of wounds, burns and immune system disorders
DE19823748C2 (de) 1998-05-27 2000-05-18 Siemens Ag Verfahren und Vorrichtung zur plasmachemischen Erzeugung von Stickstoffmonoxid
US6265420B1 (en) 1998-06-23 2001-07-24 Medinox, Inc. Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide
US20020026937A1 (en) 2000-08-28 2002-03-07 Mault James R. Respiratory gas sensors in folw path
US6673871B2 (en) 2000-12-21 2004-01-06 Kimberly-Clark Worldwide, Inc. Elastomeric articles made from a synthetic polymer
WO2003006427A1 (en) 2001-07-12 2003-01-23 Johns Hopkins University Compounds that release nitric oxide at controlled rates upon photolysis
US6673338B1 (en) 2001-09-10 2004-01-06 The United States Of America As Represented By The Department Of Health And Human Services Nitric oxide-releasing imidate and thioimidate diazeniumdiolates, compositions, uses thereof and method of making same
DE10147036A1 (de) 2001-09-25 2003-04-30 Tesa Ag Verfahren zum Delaminieren einer zumindest einschichtigen ersten Bahn von einem Laminat und zum anschließenden Laminieren einer zumindest einschichtigen weiten Bahn auf das Restlaminat
US20030039697A1 (en) 2002-09-12 2003-02-27 Yi-Ju Zhao Matrices containing nitric oxide donors and reducing agents and their use
CA2588744A1 (en) 2004-11-29 2006-06-01 The University Of Akron Topical nitric oxide donor devices and methods for their therapeutic use
US9801902B2 (en) 2006-01-17 2017-10-31 The University Of Akron Debridement method using topical nitric oxide donor devices and compositions
EP3023389B1 (de) 2006-07-05 2020-03-18 BSN medical GmbH Vorrichtung zur photolytischen erzeugung von stickstoffmonoxid
EP2051935B1 (en) 2006-07-26 2016-09-07 STMicroelectronics Srl Use of nitroaniline derivatives for the production of nitric oxide
US8877508B2 (en) * 2007-10-30 2014-11-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
WO2009155689A1 (en) * 2008-06-24 2009-12-30 Micropharma Limited Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections
DE102008038595A1 (de) 2008-08-21 2010-02-25 Tesa Se Verfahren zur Herstellung von bandförmigen Laminaten
EP2179749B1 (de) 2008-10-23 2012-08-08 Paul Hartmann AG Polyurethangelschäume
CN103127504A (zh) * 2011-12-05 2013-06-05 尼奥克斯(文莱)控股有限公司 局部产生一氧化氮的组合物和方法

Also Published As

Publication number Publication date
EP2981301A1 (de) 2016-02-10
CA2931174C (en) 2022-03-22
BR112016009986B1 (pt) 2020-12-29
CN105979975A (zh) 2016-09-28
US20160296655A1 (en) 2016-10-13
EP2981301B1 (de) 2016-11-30
JP6568519B2 (ja) 2019-08-28
CA2931174A1 (en) 2015-05-14
CN105979975B (zh) 2020-01-21
US10543293B2 (en) 2020-01-28
WO2015067746A1 (de) 2015-05-14
AU2014345526A1 (en) 2016-06-23
MX2016005642A (es) 2016-10-28
JP2017504560A (ja) 2017-02-09
AU2014345526B2 (en) 2018-03-15

Similar Documents

Publication Publication Date Title
MX351120B (es) Apósito médico.
CY1122671T1 (el) Θεραπευτικως δραστικες ενωσεις και οι μεθοδοι χρησεις αυτων
HK1219916A1 (zh) 用於同位素源外部束放療的系統和方法
MX2016003129A (es) Terapia de combinacion de anticuerpos contra el csf-1r humano y anticuerpos contralel pd-l1 humano.
CL2015002472A1 (es) Como inhibidores de mutant idh-yl-oxazolidin-2-onas 3-pirimidin-4.
MX2017004737A (es) Moduladores de cancer de tiroides de osaka (cot) y metodos de uso de los mismos.
TN2015000349A1 (en) CDC7 Inhibitors
CL2015002562A1 (es) Anticuerpos e inmunoconjugados anti-b7-h4
CA151928S (en) Electronic toothbrush
MX2015014500A (es) Terapia de combinacion de anticuerpos contra csf-1r y agonista de tlr9.
CA152182S (en) Electric foot file
DK3447136T3 (da) Carbohydratdegraderende polypeptid og anvendelser deraf
EP2942852A4 (en) EMERGENCY GENERATOR
WO2013177187A3 (en) Synergistic tumor treatment with extended-pk il-2 and therapeutic agents
CA151931S (en) Light therapy device
ZA201706402B (en) C.novyi for the treatment of solid tumors in humans
SG10201405683YA (en) Emission Source And Method Of Forming The Same
TR201910835T4 (tr) Emni̇yet ci̇hazli mobi̇lya donanimi
MX2015010077A (es) Terapia de combinacion para el tratamiento de neumonia nosocomial.
DE112014005607A5 (de) Antriebssystem sowie damit ausgerüstete Profilieranlage
UY35463A (es) Formulaciones de polipéptido fc-factor ix.
EP2982414A4 (en) PARTICLE BEAM PROJECTION CHAMBER AND PARTICLE BEAM PROCESSING DEVICE
FR3002854B1 (fr) Source d'energie implantable ultrafine.
EA201690445A1 (ru) Лечение рака
EP2840579A4 (en) POROTIC PARTICLE BEAM LIGHTING DEVICE AND PARTICLE BEAM THERAPY DEVICE COMPRISING THE SAME

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: BSN MEDICAL GMBH

PD Change of proprietorship

Owner name: BSN MEDICAL GMBH